Mitsubishi Tanabe Pharma sales and marketing update

Mitsubishi's P.T. Tanabe Indonesia subsidiary launched Livalo pitavastatin in Indonesia to treat hypercholesterolemia. Mitsubishi has development and commercialization rights to the HMG- CoA reductase inhibitor in Indonesia and Taiwan under a 2009 deal with Kowa Co. Ltd. (Nagoya, Japan). ...